Market Cap 165.12M
Revenue (ttm) 18.72M
Net Income (ttm) -132.07M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -705.50%
Debt to Equity Ratio 0.00
Volume 686,100
Avg Vol 867,928
Day's Range N/A - N/A
Shares Out 107.92M
Stochastic %K 25%
Beta 0.48
Analysts Strong Sell
Price Target $9.83

Latest News on ACRS

Aclaris Therapeutics Announces $80 Million Private Placement

Nov 18, 2024, 8:10 AM EST - 4 months ago

Aclaris Therapeutics Announces $80 Million Private Placement


Aclaris Therapeutics Provides Corporate Update

Dec 19, 2023, 4:01 PM EST - 1 year ago

Aclaris Therapeutics Provides Corporate Update


Aclaris Therapeutics Provides 2023 Outlook

Jan 6, 2023, 7:01 AM EST - 2 years ago

Aclaris Therapeutics Provides 2023 Outlook


Aclaris Therapeutics Announces Key Leadership Transitions

Nov 22, 2022, 4:01 PM EST - 2 years ago

Aclaris Therapeutics Announces Key Leadership Transitions